Ruth L. Savage

Dunedin, OTA 9054, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists.

Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists.

Journal: The International journal of pharmacy practice

Published: February 19, 2026

Uncovering Pregnancy Exposures in Pharmacovigilance Case Report Databases: A Comprehensive Evaluation of the VigiBase Pregnancy Algorithm.

Uncovering Pregnancy Exposures in Pharmacovigilance Case Report Databases: A Comprehensive Evaluation of the VigiBase Pregnancy Algorithm.

Journal: Drug safety

Published: May 08, 2025

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.

Journal: Drug safety

Published: September 17, 2023

Navigating the health system during COVID-19: primary care perspectives on delayed patient care.

Navigating the health system during COVID-19: primary care perspectives on delayed patient care.

Journal: The New Zealand medical journal

Published: December 02, 2021

Empty waiting rooms: the New Zealand general practice experience with telehealth during the COVID-19 pandemic.

Empty waiting rooms: the New Zealand general practice experience with telehealth during the COVID-19 pandemic.

Journal: The New Zealand medical journal

Published: July 09, 2021

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.

Journal: Drug safety

Published: June 24, 2021

'Here to stay': changes to prescribing medication in general practice during the COVID-19 pandemic in New Zealand.

'Here to stay': changes to prescribing medication in general practice during the COVID-19 pandemic in New Zealand.

Journal: Journal of primary health care

Published: March 24, 2021

Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database.

Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database.

Journal: Drugs - real world outcomes

Published: February 28, 2021

The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports.

The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports.

Journal: ERJ open research

Published: October 30, 2020

E-Learning in Pharmacovigilance: An Evaluation of Microlearning-Based Modules Developed by Uppsala Monitoring Centre.

E-Learning in Pharmacovigilance: An Evaluation of Microlearning-Based Modules Developed by Uppsala Monitoring Centre.

Journal: Drug safety

Published: August 14, 2020

Suspected Hepatotoxicity With a Supercritical Carbon Dioxide Extract of Artemisia annua in Grapeseed Oil Used in New Zealand.

Suspected Hepatotoxicity With a Supercritical Carbon Dioxide Extract of Artemisia annua in Grapeseed Oil Used in New Zealand.

Journal: Frontiers in pharmacology

Published: August 05, 2019

The Association between Metformin Therapy and Lactic Acidosis.

The Association between Metformin Therapy and Lactic Acidosis.

Journal: Drug safety

Published: August 03, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026